Isorhapontigenin ameliorates cerebral ischemia/reperfusion injury via modulating Kinase Cε/Nrf2/HO‐1 signaling pathway

Isorhapontigenin ameliorates cerebral ischemia/reperfusion injury via modulating Kinase Cε/Nrf2/HO‐1 signaling pathway

Abstract Background Isorhapontigenin (ISO) has been shown to have antioxidant activity. This study aimed to investigate the antioxidant effects of ISO on cerebral ischemia/reperfusion (I/R) injury and its possible molecular mechanisms. Methods Focal cerebral ischemia‐reperfusion injury (MCAO/R) mode...

Full description

Bibliographic Details
Main Authors: Zhe Xue, Kai Zhao, Zhenghui Sun, Chen Wu, Bowen Yu, Dongsheng Kong, Bainan Xu
Format: Article
Language:English
Published: Wiley 2021-07-01
Series:Brain and Behavior
Subjects:
cerebral ischemia
HO‐1
isorhapontigenin
Nrf2
oxidative stress
PKCε
Online Access:https://doi.org/10.1002/brb3.2143

Internet

https://doi.org/10.1002/brb3.2143

Similar Items